Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to compare the treatment effect at week 26 between the two groups, sulfonylurea (SU, glimepiride) administration and thiazolidinedione (TZD, Pioglitazone) administration, as the third-order drug among patients whose treatment is not sufficient after the combined administration of Metformin and Alogliptin.
Epistemonikos ID: 40af018996a11b41bb028c9e4b2f46bcc4c31083
First added on: May 12, 2024